Medterra CBD announced in a recent press release that the National Animal Supplement Council (NASC) has approved the brand’s line of pet care products, which include beef, chicken, unflavored tinctures, and pet chews.
Bill Bookout, the President of NASC, shared in the press release the qualification requirement for NASC membership. He stated,
“To qualify for NASC membership a company must sign a written agreement to adhere to our comprehensive quality requirements. Medterra demonstrates their commitment to these objectives by their ‘Seed to Sale' quality philosophy that is not just articulated, but is also evidenced in the actions of their company. We welcome Medterra as a new member that will help continue to shape the future of the cannabis industry for the benefit of companion animals.”
The company also discussed its new partnerships in the press release. Medterra partnered with Chuck Latham Associates, Inc. This partnership enables the company to distribute its products through the organization’s retail, manufacturer, and distributor network. The network specializes in pet care products, and features over 1,000 pet experts around the country.
Jason Dorfman, the Vice President of Medterra CBD, shared in the press release,
“The missions of both the NASC and CLA are very similar to ours. Providing products that are of the highest quality and backed by research are at the center of all that we do.”
Baylor College of Medicine was recently commissioned by the brand to conduct clinical trials on the brand’s Pet Products with outpatient senior dogs that are suffering from arthritis. The trials measured the efficacy of the brand’s products. The results indicated that 80% of participating dogs experience “some level of benefit, including an increase in willingness to play and run, and ease in lying and standing after using Medterra’s Pet Products.”
All information is for general informational and educational purposes only. Nothing should be interpreted as legal or medical advice.